Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice
暂无分享,去创建一个
Chris I. De Zeeuw | Ben A. Oostra | David L. Nelson | Herma C. van der Linde | Rob Willemsen | C. I. Zeeuw | S. Koekkoek | D. Nelson | B. Oostra | R. Willemsen | Femke M.S. de Vrij | Josien Levenga | Sebastiaan K. Koekkoek | J. Levenga | F. D. Vrij | H. V. D. Linde | B. Oostra
[1] W. Greenough,et al. Sequence of abnormal dendritic spine development in primary somatosensory cortex of a mouse model of the fragile X mental retardation syndrome , 2005, American journal of medical genetics. Part A.
[2] N. Gekakis,et al. Obesity, hyperphagia and increased metabolic efficiency in Pc1 mutant mice. , 2006, Human molecular genetics.
[3] K. Marquis,et al. Intracerebral administration of metabotropic glutamate receptor agonists disrupts prepulse inhibition of acoustic startle in Sprague-Dawley rats , 1999, Psychopharmacology.
[4] G. Bassell,et al. Localization of FMRP‐associated mRNA granules and requirement of microtubules for activity‐dependent trafficking in hippocampal neurons , 2005, Genes, brain, and behavior.
[5] Mark F. Bear,et al. Altered synaptic plasticity in a mouse model of fragile X mental retardation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[6] M. Geyer,et al. The mGluR5 antagonist MPEP, but not the mGluR2/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity , 2002, Neuropharmacology.
[7] J. Darnell,et al. Fragile X Mental Retardation Protein Targets G Quartet mRNAs Important for Neuronal Function , 2001, Cell.
[8] I. Weiler,et al. Fragile X mental retardation protein is necessary for neurotransmitter-activated protein translation at synapses. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[9] Jens-Uwe Peters,et al. Fenobam: A Clinically Validated Nonbenzodiazepine Anxiolytic Is a Potent, Selective, and Noncompetitive mGlu5 Receptor Antagonist with Inverse Agonist Activity , 2005, Journal of Pharmacology and Experimental Therapeutics.
[10] Mark F. Bear,et al. Correction of Fragile X Syndrome in Mice , 2007, Neuron.
[11] D. Nelson,et al. The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo , 2006, Neurobiology of Disease.
[12] Mark F. Bear,et al. Internalization of ionotropic glutamate receptors in response to mGluR activation , 2001, Nature Neuroscience.
[13] M. Tranfaglia,et al. Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP , 2005, Neuropharmacology.
[14] I. Weiler,et al. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[15] M. Segal,et al. FMRP involvement in formation of synapses among cultured hippocampal neurons. , 2000, Cerebral cortex.
[16] D. Nelson,et al. Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins. , 2006, Human molecular genetics.
[17] Raffaele Ferri,et al. Audiogenic Seizures Susceptibility in Transgenic Mice with Fragile X Syndrome , 2000, Epilepsia.
[18] Alcino J. Silva,et al. Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice , 2004, Molecular Psychiatry.
[19] S. Grant,et al. A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability , 2007, Nature Neuroscience.
[20] C I De Zeeuw,et al. Monitoring kinetic and frequency-domain properties of eyelid responses in mice with magnetic distance measurement technique. , 2002, Journal of neurophysiology.
[21] Karel Svoboda,et al. Abnormal Development of Dendritic Spines inFMR1 Knock-Out Mice , 2001, The Journal of Neuroscience.
[22] A. Faden,et al. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors , 2005, British journal of pharmacology.
[23] I. Weiler,et al. Local Protein Synthesis and Spine Morphogenesis: Fragile X Syndrome and Beyond , 2006, The Journal of Neuroscience.
[24] I. Weiler,et al. RNA Cargoes Associating with FMRP Reveal Deficits in Cellular Functioning in Fmr1 Null Mice , 2003, Neuron.
[25] Christina Gross,et al. Dysregulated Metabotropic Glutamate Receptor-Dependent Translation of AMPA Receptor and Postsynaptic Density-95 mRNAs at Synapses in a Mouse Model of Fragile X Syndrome , 2007, The Journal of Neuroscience.
[26] Stephen T Warren,et al. Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors , 2007, Proceedings of the National Academy of Sciences.
[27] W. Greenough,et al. From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome , 2005, Nature Reviews Neuroscience.
[28] E. De Schutter,et al. Deletion of FMR1 in Purkinje Cells Enhances Parallel Fiber LTD, Enlarges Spines, and Attenuates Cerebellar Eyelid Conditioning in Fragile X Syndrome , 2005, Neuron.
[29] Mariette Schrier,et al. Transport of Fragile X Mental Retardation Protein via Granules in Neurites of PC12 Cells , 2002, Molecular and Cellular Biology.
[30] J. Darnell,et al. FMRP RNA targets: identification and validation , 2005, Genes, brain, and behavior.
[31] R. Carroll,et al. Local functions for FMRP in axon growth cone motility and activity-dependent regulation of filopodia and spine synapses , 2006, Molecular and Cellular Neuroscience.
[32] Yan Wang,et al. Pharmacological Rescue of Synaptic Plasticity, Courtship Behavior, and Mushroom Body Defects in a Drosophila Model of Fragile X Syndrome , 2005, Neuron.
[33] I. Weiler,et al. Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[34] P. Popoli,et al. Neuroprotective effects of the mGlu5R antagonist MPEP towards quinolinic acid‐induced striatal toxicity: involvement of pre‐ and post‐synaptic mechanisms and lack of direct NMDA blocking activity , 2004, Journal of neurochemistry.
[35] Yasushi Miyashita,et al. Dendritic spine geometry is critical for AMPA receptor expression in hippocampal CA1 pyramidal neurons , 2001, Nature Neuroscience.
[36] W. Brown,et al. Analysis of neocortex in three males with the fragile X syndrome. , 1991, American journal of medical genetics.
[37] A. Ostareck-Lederer,et al. Evidence that fragile X mental retardation protein is a negative regulator of translation. , 2001, Human molecular genetics.
[38] M. Bear,et al. Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression. , 2000, Science.
[39] S. Warren,et al. The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[40] M. Segal,et al. Morphological analysis of dendritic spine development in primary cultures of hippocampal neurons , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[41] Guy Nagels,et al. Fmr1 knockout mice: A model to study fragile X mental retardation , 1994, Cell.
[42] É. Khandjian,et al. The fragile X syndrome: exploring its molecular basis and seeking a treatment , 2006, Expert Reviews in Molecular Medicine.
[43] D. McIntosh,et al. Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: a preliminary report. , 1999, American journal of medical genetics.
[44] Liang Li,et al. Metabotropic glutamate subtype 5 receptors modulate fear-conditioning induced enhancement of prepulse inhibition in rats , 2007, Neuropharmacology.
[45] Y. Hiraoka,et al. Cadherin activity is required for activity-induced spine remodeling , 2004, The Journal of cell biology.
[46] Mark F Bear,et al. The mGluR theory of fragile X mental retardation , 2004, Trends in Neurosciences.
[47] I. Weiler,et al. Synaptic regulation of protein synthesis and the fragile X protein , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[48] M. Bellomo,et al. Endogenous Activation of Group-I Metabotropic Glutamate Receptors Is Required for Differentiation and Survival of Cerebellar Purkinje Cells , 2001, The Journal of Neuroscience.
[49] Yue Feng,et al. Dynamic association of the fragile X mental retardation protein as a messenger ribonucleoprotein between microtubules and polyribosomes. , 2008, Molecular biology of the cell.
[50] J. Darnell,et al. The fragile X mental retardation protein, FMRP, recognizes G-quartets. , 2004, Mental retardation and developmental disabilities research reviews.